Financial reports
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
10-K
2021 FY
Annual report
1 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
13 Aug 21
10-Q
2021 Q1
Quarterly report
14 May 21
10-K
2020 FY
Annual report
30 Mar 21
10-Q
2020 Q3
Quarterly report
12 Nov 20
10-Q
2020 Q2
Quarterly report
13 Aug 20
Current reports
8-K
Termination of a Material Definitive Agreement
14 Oct 22
8-K
Tender and Support Agreement
1 Sep 22
8-K
Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
5 Aug 22
8-K
Departure of Directors or Certain Officers
25 Jul 22
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 22
8-K
Regulation FD Disclosure
26 May 22
8-K
Forma Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
6 May 22
8-K
Forma Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Update
1 Mar 22
8-K
Departure of Directors or Certain Officers
13 Jan 22
8-K
First Phase 2 combination trial results presented in oral session at 2021 ASH Annual Meeting
16 Dec 21
Registration and prospectus
15-12G
Securities registration termination
24 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Oct 22
POS AM
Prospectus update (post-effective amendment)
14 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Oct 22
SC 14D9/A
Tender offer solicitation (amended)
14 Oct 22
SC TO-T/A
Third party tender offer statement (amended)
14 Oct 22
25-NSE
Exchange delisting
14 Oct 22
SC 14D9/A
Tender offer solicitation (amended)
7 Oct 22
Other
EFFECT
Notice of effectiveness
18 Oct 22
UPLOAD
Letter from SEC
26 Sep 22
EFFECT
Notice of effectiveness
4 May 22
EFFECT
Notice of effectiveness
11 Dec 20
CORRESP
Correspondence with SEC
8 Dec 20
CORRESP
Correspondence with SEC
8 Dec 20
UPLOAD
Letter from SEC
17 Nov 20
EFFECT
Notice of effectiveness
19 Jun 20
CERT
Certification of approval for exchange listing
17 Jun 20
CORRESP
Correspondence with SEC
16 Jun 20
Ownership